<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01010035</url>
  </required_header>
  <id_info>
    <org_study_id>LIPIDSDM</org_study_id>
    <nct_id>NCT01010035</nct_id>
  </id_info>
  <brief_title>Cholesterol Metabolism and Lipid Transfer in Diabetes</brief_title>
  <official_title>Plasma Kinetics Study of Free Cholesterol and Cholesteryl Ester in Type 2 Diabetes Mellitus Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The diabetic dyslipidemia is one of the most important risk factor in the development of
      coronary artery disease. The low density lipoprotein (LDL)-like nanoemulsions is being used
      to study the clearance of cholesteryl ester and free cholesterol from intravascular in
      patients with advanced coronary artery disease and it was shown a higher removal of free
      cholesterol and higher deposit in vases of this patients. The aim of this study is to analyze
      the plasma kinetics of both forms of cholesterol(free ad esterified) in type 2 diabetes
      patients without a previous history of cardiovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypercholesterolemia is not typical of type 2 diabetes mellitus dyslipidemia, but alterations
      in LDL may occur related to atherogenesis.Cholesterol exist in two main forms in organism:
      free cholesterol and the esterified cholesterol. An artificial model to study this two forms
      of cholesterol is the use of LDL-like nanoemulsion doubly labeled with 14C-cholesteryl esters
      and 3H- cholesterol. This nanoemulsion is made without protein and when in the intravascular
      compartment it is able to acquires apolipoproteins from others lipoproteins, such apos A's,
      C's and E. This model allowed us to use the nanoemulsion particle as a probe to study the
      lipoproteins receptor binding and the cholesterol esterification process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>to identify the removal of the free and esterified cholesterol in type 2 diabetes patients</measure>
    <time_frame>day of test</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>type 2 diabetes</arm_group_label>
    <description>patients with diagnosis of Type 2 diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>non type 2 diabetes mellitus</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Plasma kinetic study</intervention_name>
    <description>this study is done with the injection of LDL-like nanoemulsion doubly labeled with 14C- cholesteryl oleate and 3H- cholesterol, with a total radioactivity injection dose of 0.03mSV. Blood sample collected in a pre established period of time in 24 hours.</description>
    <arm_group_label>type 2 diabetes</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>LDL-like nanoemulsion</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        outpatient of the endocrinology clinics of Hospital das clinicas of University of São Paulo
        Medical school
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  without a previous cardiovascular disease

          -  if arterial hypertension, or in use of antihypertensive drugs- it must be well
             controled with a systolic Blood pressure level &lt;130mmHg and diastolic &lt;85mmHg.

          -  total cholesterol &lt; 6 mmol/L

          -  LDL- cholesterol &lt;4 mmol/L

        Exclusion Criteria:

          -  use of drugs- statins, fibrates, glucocorticoids, thiazolidinediones

          -  nephropathy- the presence of microalbuminuria(ratio of microalbuminuria/creatinin &gt;30
             ug/mg) or serum creatinin above 98umol/L in woman and above 115 umol/L in man

          -  retinopathy

          -  neuropathy presence of chronic disease: heart failure, chronic obstructive pulmonary
             disease, inflammatory disease and cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio C Lerario, MD, pHd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of São Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinology service and Lipid laboratory of Heart Institute of University of São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05423000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhão RC. Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. J Lipid Res. 2003 Mar;44(3):464-9. Epub 2002 Dec 1.</citation>
    <PMID>12562871</PMID>
  </reference>
  <reference>
    <citation>Santos RD, Chacra AP, Morikawa A, Vinagre CC, Maranhão RC. Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin. Lipids. 2005 Jul;40(7):737-43.</citation>
    <PMID>16196425</PMID>
  </reference>
  <reference>
    <citation>Couto RD, Dallan LA, Lisboa LA, Mesquita CH, Vinagre CG, Maranhão RC. Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis. Lipids. 2007 May;42(5):411-8. Epub 2007 Apr 19.</citation>
    <PMID>17443358</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2009</study_first_submitted>
  <study_first_submitted_qc>November 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2009</study_first_posted>
  <last_update_submitted>November 6, 2009</last_update_submitted>
  <last_update_submitted_qc>November 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>Antonio Carlos Lerario/ MD, PhD</name_title>
    <organization>university of são Paulo</organization>
  </responsible_party>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>dyslipidemia</keyword>
  <keyword>kinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

